Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Ofatumumab in Refractory/Relapsed CLL
NCT01244451Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Dec 2010
- Primary completion
- Jul 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by GIMEMA. Started Dec 2010; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01244451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244451.